3rd Quarter - Report — IONIS PHARMACEUTICALS, INC. for IONIS PHARMACEUTICALS, INC. (2025)

Firm

IONIS PHARMACEUTICALS, INC.

Client

IONIS PHARMACEUTICALS, INC.

Income

—

Expenses

$140,000

Expense method

A: Lobbying Disclosure Act definitions

What was lobbied

3 issue areas, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

Issues related to the implementation of the Inflation Reduction Act. H.R.1672 - Maintaining Investments in New Innovation Act. H.R.1262/S.932 - Give Kids a Chance Act of 2025. H.R.946/S.1862 - ORPHAN Cures Act. H.R.1492/S.832 - EPIC Act.

Lobbyist	Covered position, as disclosed
JORDAN CHAPMAN	—

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: S. 832 (119th), H.R. 1672 (119th), S. 932 (119th), H.R. 1262 (119th), H.R. 946 (119th), S. 1862 (119th), H.R. 1492 (119th)

Medicare/Medicaid MMM

Issues related to the implementation of the Inflation Reduction Act. H.R.1672 - Maintaining Investments in New Innovation Act. H.R.946/S.1862 - ORPHAN Cures Act. H.R.1492/S.832 - EPIC Act. Issues related to the Medicaid rebate.

Lobbyist	Covered position, as disclosed
JORDAN CHAPMAN	—

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: S. 832 (119th), S. 1862 (119th), H.R. 1492 (119th), H.R. 1672 (119th), H.R. 946 (119th)

Taxation/Internal Revenue Code TAX

Issues related to the implementation of the Tax Cuts and Jobs Act of 2017. H.R.1414 - Camerons Law.

Lobbyist	Covered position, as disclosed
JORDAN CHAPMAN	—

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: H.R. 1414 (119th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.